OccuLogix buys into glaucoma treatment technology
This article was originally published in Clinica
Executive Summary
OccuLogix has definitively agreed to acquire Solx, a company focused on glaucoma treatment, in a move to diversify its product portfolio into other areas of age-related ophthalmic diseases.